C12Y 208/02023
[heparan sulfate]-glucosamine 3-sulfotransferase 1
Official title: [Heparan sulfate]-glucosamine 3-sulfotransferase 1 (2.8.2.23)
C12Y208/02023 ([heparan sulfate]-glucosamine 3-sulfotransferase 1) appears on 12 US grants and 24 published applications in this corpus.
Search patents in C12Y- Granted patents
- 12
- Published applications
- 24
- Assignees
- 18
- Inventors
- 30
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 4 |
| 2022 | 1 | 4 |
| 2023 | 9 | 6 |
| 2024 | 0 | 2 |
| 2025 | 0 | 3 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- In vitro heparin and heparan sulfate compositions and methods of making and using26 May 2026US 12,636,307 B2TEGA Therapeutics, Inc.
- Engineered aryl sulfate-dependent enzymes3 Oct 2023US 11,773,382 B2Optimvia, LLC
- Engineered aryl sulfate-dependent enzymes26 Sep 2023US 11,767,518 B2Optimvia, LLC
- Engineered aryl sulfate-dependent enzymes25 Jul 2023US 11,708,567 B2Optimvia, LLC
- Engineered aryl sulfate-dependent enzymes25 Jul 2023US 11,708,593 B2Optimvia, LLC
- Compositions and methods for treating acute respiratory distress syndrome18 Jun 2026US 2026/0166087 A1Direct Biologics, LLC
- Anticoagulant heparin-chondroitin chimeric saccharide molecule as well as preparation method and application thereof12 Jun 2025US 2025/0188506 A1Shandong University
- Improved heparan sulfate and methods of making the same15 May 2025US 2025/0154476 A1University of Copenhagen
- Genetically modified mouse models and methods of use thereof10 Apr 2025US 2025/0113809 A1University of South Florida
- Engineered aryl sulfate-dependent enzymes21 Mar 2024US 2024/0093166 A1Optimvia, LLC
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.